Dominika Kaźmierczak

Author

Poznan University of Medical Sciences ORCID

Also Known As

Dominika Kazmierczak, Dominika Kaźmierczak, Dominika Kaźmierczak

Publications

267

Citations

H-Index

Concepts

All Affiliations

Poznan University of Medical Sciences Heliodor Swiecicki Clinical Hospital University of Zielona Góra Karolinska Institutet Karolinska University Hospital

About

Dominika Kaźmierczak is an author at Poznan University of Medical Sciences specializing in cell biology, medicine, and oogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	85
2	Cell Biology	2	2	85
3	Health Sciences	1	1	49
4	Public Health	1	1	36
5	Pathology	1	1	49

Dominika Kaźmierczak

Publications

264

Citations

H-Index

Page 1

	Year	Citations
Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development Karolina Sterzyńska, Andrzej Klejewski, Karolina Wojtowicz, International Journal of Molecular Sciences PathologyCancer BiologyTumor BiologyOvarian CancerDrug Resistance	2018	49
Morphogenesis-related gene-expression profile in porcine oocytes before and after <i>in vitro</i> maturation Joanna Budna, Adrian Chachuła, Dominika Kaźmierczak, Zygote OocyteOocyte MorphogenesisFertilityGeneticsReproductive Biology	2017	36
The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska, International Journal of Molecular Sciences	2020	27
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines Monika Świerczewska, Andrzej Klejewski, Maciej Brązert, Molecules	2018	25
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines Karolina Sterzyńska, Dominika Kaźmierczak, Andrzej Klejewski, International Journal of Molecular Sciences	2019	22
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations Monika Świerczewska, Karolina Sterzyńska, Karolina Wojtowicz, International Journal of Molecular Sciences	2019	21
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska, International Journal of Molecular Sciences	2022	21
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer Dominika Kaźmierczak, Inger Johanne Zwicky Eide, Radosveta Gencheva, Translational Lung Cancer Research	2022	19
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines Piotr Stasiak, Dominika Kaźmierczak, Karol Jopek, International Journal of Molecular Sciences	2022	14
A MicroRNA Gene Panel Predicts the Vaginal Microbiota Composition Liqin Cheng, Dominika Kaźmierczak, Johanna Norenhag, mSystems	2021	10

Page 1